Hideki Doi

2.6k total citations
48 papers, 2.0k citations indexed

About

Hideki Doi is a scholar working on Molecular Biology, Surgery and Cellular and Molecular Neuroscience. According to data from OpenAlex, Hideki Doi has authored 48 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Surgery and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Hideki Doi's work include Muscle Physiology and Disorders (7 papers), Genetic Neurodegenerative Diseases (7 papers) and Cardiac Imaging and Diagnostics (5 papers). Hideki Doi is often cited by papers focused on Muscle Physiology and Disorders (7 papers), Genetic Neurodegenerative Diseases (7 papers) and Cardiac Imaging and Diagnostics (5 papers). Hideki Doi collaborates with scholars based in Japan, United States and Greece. Hideki Doi's co-authors include Hirofumi Yasue, Seigo Sugiyama, Kiyotaka Kugiyama, Toshiyuki Matsumura, Hideki Oka, Nobuhiko Ogata, Hirofumi Soejima, Yasutaka Ota, Hiroaki Kawano and Hisao Ogawa and has published in prestigious journals such as Circulation, Nature Medicine and Nature Communications.

In The Last Decade

Hideki Doi

46 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hideki Doi Japan 22 693 579 557 488 341 48 2.0k
Satoshi Imaizumi Japan 26 654 0.9× 840 1.5× 644 1.2× 500 1.0× 365 1.1× 97 2.4k
Yasuki Ito Japan 36 884 1.3× 1.2k 2.1× 473 0.8× 1.5k 3.0× 401 1.2× 202 4.8k
Héctor De León United States 23 689 1.0× 375 0.6× 615 1.1× 215 0.4× 172 0.5× 49 2.0k
Abel L. Robertson United States 23 594 0.9× 409 0.7× 529 0.9× 300 0.6× 158 0.5× 52 2.1k
Jonathan E. Feig United States 25 925 1.3× 1.0k 1.8× 439 0.8× 337 0.7× 410 1.2× 35 3.1k
Kenichiro Okada Japan 22 840 1.2× 449 0.8× 442 0.8× 186 0.4× 125 0.4× 75 2.4k
Sadao Takahashi Japan 25 780 1.1× 639 1.1× 524 0.9× 424 0.9× 317 0.9× 60 1.9k
Jun Ishii Japan 28 700 1.0× 473 0.8× 238 0.4× 718 1.5× 190 0.6× 152 2.4k
Fina Lovren Canada 26 950 1.4× 330 0.6× 776 1.4× 211 0.4× 354 1.0× 45 2.7k
Ken‐ichi Kawabata Japan 30 526 0.8× 594 1.0× 1.2k 2.2× 247 0.5× 159 0.5× 113 2.6k

Countries citing papers authored by Hideki Doi

Since Specialization
Citations

This map shows the geographic impact of Hideki Doi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Doi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Doi more than expected).

Fields of papers citing papers by Hideki Doi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideki Doi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Doi. The network helps show where Hideki Doi may publish in the future.

Co-authorship network of co-authors of Hideki Doi

This figure shows the co-authorship network connecting the top 25 collaborators of Hideki Doi. A scholar is included among the top collaborators of Hideki Doi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideki Doi. Hideki Doi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Moriyama, Shuji, Masahiko Hara, Takafumi Hirota, et al.. (2023). Population-Based Study of the Incidence and Mortality Rate of Acute Aortic Dissection. Circulation Journal. 88(3). 297–306. 4 indexed citations
3.
Doi, Hideki, et al.. (2022). Efficacy of pressure gradient measurement using peripheral fractional flow reserve in common femoral artery: a case report. European Heart Journal - Case Reports. 6(11). ytac426–ytac426. 2 indexed citations
4.
Sonoda, Shinjo, et al.. (2019). Acute myocardial infarction following sequential multi-vessel occlusion in a case of polycythemia vera. Journal of Cardiology Cases. 20(4). 111–114. 4 indexed citations
5.
Kawarada, Osami, Akihiro Higashimori, Yoshiaki Yokoi, et al.. (2017). Predictors of cardiac benefits of renal artery stenting from a multicentre retrospective registry. Heart Asia. 9(2). e010934–e010934. 1 indexed citations
6.
Tohnai, Genki, Hiroaki Adachi, Masahisa Katsuno, et al.. (2014). Paeoniflorin eliminates a mutant AR via NF-YA-dependent proteolysis in spinal and bulbar muscular atrophy. Human Molecular Genetics. 23(13). 3552–3565. 30 indexed citations
7.
Kondo, Naohide, Masahisa Katsuno, Hiroaki Adachi, et al.. (2013). Heat shock factor-1 influences pathological lesion distribution of polyglutamine-induced neurodegeneration. Nature Communications. 4(1). 1405–1405. 44 indexed citations
8.
Miyazaki, Yu, Hiroaki Adachi, Masahisa Katsuno, et al.. (2012). Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2. Nature Medicine. 18(7). 1136–1141. 118 indexed citations
9.
Minamiyama, Makoto, Masahisa Katsuno, Hiroaki Adachi, et al.. (2012). Naratriptan mitigates CGRP1-associated motor neuron degeneration caused by an expanded polyglutamine repeat tract. Nature Medicine. 18(10). 1531–1538. 30 indexed citations
10.
Katsuno, Masahisa, Hiroaki Adachi, Makoto Minamiyama, et al.. (2010). Disrupted Transforming Growth Factor-β Signaling in Spinal and Bulbar Muscular Atrophy. Journal of Neuroscience. 30(16). 5702–5712. 66 indexed citations
11.
Doi, Hideki, et al.. (2009). Rare Metal Recovery and Recycling in Consumer-electronics Production. Material Cycles and Waste Management Research. 20(2). 77–84. 1 indexed citations
12.
Tokui, Keisuke, Hiroaki Adachi, Masahiro Waza, et al.. (2008). 17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse. Human Molecular Genetics. 18(5). 898–910. 98 indexed citations
14.
Kugiyama, Kiyotaka, Seigo Sugiyama, Hirofumi Soejima, et al.. (2001). Increase in plasma levels of oxidized low-density lipoproteins in patients with coronary spastic angina. Atherosclerosis. 154(2). 463–467. 29 indexed citations
15.
Kugiyama, Kiyotaka, Yasutaka Ota, Seigo Sugiyama, et al.. (2000). Prognostic value of plasma levels of secretory type II phospholipase A2 in patients with unstable angina pectoris. The American Journal of Cardiology. 86(7). 718–722. 68 indexed citations
16.
Kugiyama, Kiyotaka, Takeshi Motoyama, Hideki Doi, et al.. (1999). Improvement of endothelial vasomotor dysfunction by treatment with alpha-tocopherol in patients with high remnant lipoproteins levels. Journal of the American College of Cardiology. 33(6). 1512–1518. 51 indexed citations
17.
Murohara, Toyoaki, Kiyotaka Kugiyama, Yasutaka Ota, et al.. (1999). Effects of Atrial and Brain Natriuretic Peptides on Lysophosphatidylcholine-Mediated Endothelial Dysfunction. Journal of Cardiovascular Pharmacology. 34(6). 870–878. 15 indexed citations
18.
Doi, Hideki, Kiyotaka Kugiyama, Masamichi Ohgushi, et al.. (1998). Remnants of chylomicron and very low density lipoprotein impair endothelium-dependent vasorelaxation. Atherosclerosis. 137(2). 341–349. 108 indexed citations
19.
Ota, Yasutaka, Kiyotaka Kugiyama, Seigo Sugiyama, et al.. (1997). Impairment of endothelium-dependent relaxation of rabbit aortas by cigarette smoke extract—role of free radicals and attenuation by captopril. Atherosclerosis. 131(2). 195–202. 130 indexed citations
20.
Arakawa, K, Junichi Sasaki, Keijiro Saku, et al.. (1988). Effect of Ketanserin on Lipoproteins in Patients with Essential Hypertension. Drugs. 36(Supplement 1). 126–129. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026